Reciprocal Regulation of HSD11B1 and HSD11B2 Predicts Glucocorticoid Sensitivity in Childhood Acute Lymphoblastic Leukemia

Copyright © 2020 Elsevier Inc. All rights reserved..

There are few biomarkers to predict efficacy of glucocorticoid treatment in childhood acute lymphoblastic leukemia (ALL) at diagnosis. Here, we demonstrate reciprocal regulation of 11beta-hydroxysteroid dehydrogenase (11β-HSD), may predict the apoptotic response of ALL to glucocorticoid treatment. Our data may be useful to refine glucocorticoid treatment, to retain benefit while minimizing side effects.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:220

Enthalten in:

The Journal of pediatrics - 220(2020) vom: 22. Mai, Seite 249-253

Sprache:

Englisch

Beteiligte Personen:

Sai, Shuji [VerfasserIn]
Esteves, Cristina [VerfasserIn]
Kelly, Val [VerfasserIn]
Sakaguchi, Kimiyoshi [VerfasserIn]
McAndrew, Rachel [VerfasserIn]
Chudleigh, Sandra [VerfasserIn]
Spence, Alison [VerfasserIn]
Gibson, Brenda [VerfasserIn]
Thomas, Angela [VerfasserIn]
Chapman, Karen E [VerfasserIn]

Links:

Volltext

Themen:

11β-HSD
11-beta-Hydroxysteroid Dehydrogenase Type 1
11-beta-Hydroxysteroid Dehydrogenase Type 2
7S5I7G3JQL
9PHQ9Y1OLM
Dexamethasone
EC 1.1.1.146
Glucocorticoid resistance
Glucocorticoids
HSD11B1 protein, human
HSD11B2 protein, human
Journal Article
Leukemia
Prednisolone
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 24.09.2020

Date Revised 24.09.2020

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.jpeds.2019.12.054

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM305838490